KACI WEAVER: Open Payments
NPI 1740670280 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,889 in 97 payments from 21 companies in 2025. Trend: 2023 $1,447 · 2024 $2,086 · 2025 $1,889
Food & beverage: $1,875Entertainment: $14
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $299 |
| AstraZeneca Pharmaceuticals LP | 13 | $273 |
| PFIZER INC. | 16 | $229 |
| Novo Nordisk Inc | 9 | $169 |
| ABBVIE INC. | 10 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $117 |
| INTUITIVE SURGICAL, INC. | 1 | $93 |
| Amgen Inc. | 5 | $91 |
| Astellas Pharma US Inc | 3 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $63 |
Products named: GEMTESA, NURTEC ODT, BREZTRI, Kerendia, FARXIGA, Ozempic, Da Vinci Surgical System, REXULTI.
Industry payments across AL — which companies pay providers there.
